New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2013
14:17 EDTDVAXDynavax volatility elevated into PDUFA
Dynavax overall option implied volatility of 137 is above its 26-week average of 97 according to Track Data, suggesting larger price movement into PDUFA Date for Heplisav in late February.
News For DVAX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 23, 2015
10:00 EDTDVAXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:23 EDTDVAXDynavax upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded Dynavax to Overweight saying it is now "significantly more comfortable" with the safety of the company's Heplisav vaccine for hepatitis B. The firm raised its price target for shares to $36 from $15.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use